ArticleMolecular therapy : the journal of the American Society of Gene Therapy2015

Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy.

Mahesh Jonnalagadda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.